Reichinger, A; Taghizadeh, H; Lentner, TK; Reimann, P; Winder, T; Kiesl, D; Romeder, F; Webersinke, G; Burghofer, J; Kirchweger, P; Riedl, JM; Prager, G; Rumpold, H; Doleschal, B.
Real-world assessment of NALIRIFOX for advanced pancreatic ductal adenocarcinoma: An exploratory analysis
ANN ONCOL. 2024; 35: S929-S929.
Doi: 10.1016/j.annonc.2024.08.1583
Web of Science
FullText
FullText_MUG